216 related articles for article (PubMed ID: 35274820)
1. Improved risk scoring systems for colorectal cancer screening in Shanghai, China.
Wu WM; Gu K; Yang YH; Bao PP; Gong YM; Shi Y; Xu WH; Fu C
Cancer Med; 2022 May; 11(9):1972-1983. PubMed ID: 35274820
[TBL] [Abstract][Full Text] [Related]
2. Risk Scoring Systems for Predicting the Presence of Colorectal Neoplasia by Fecal Immunochemical Test Results in Chinese Population.
Wu W; Chen X; Fu C; Wong MCS; Bao P; Huang J; Gong Y; Xu W; Gu K
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00525. PubMed ID: 36007185
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population-based program and meta-analysis.
Wang Z; Teng J; Wu W; Dou J; Wong MCS; Gong Y; Huang J; Gu K; Xu W
Cancer Med; 2023 Sep; 12(17):18189-18200. PubMed ID: 37578430
[TBL] [Abstract][Full Text] [Related]
4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
5. A risk scoring system for advanced colorectal neoplasia in high-risk participants to improve current colorectal cancer screening in Tianjin, China.
Yuan Z; Wang S; Liu Z; Liu Y; Wang Y; Han Y; Gao W; Liu X; Li H; Zhang Q; Ma H; Wang J; Wei X; Zhang X; Cui W; Zhang C
BMC Gastroenterol; 2022 Nov; 22(1):466. PubMed ID: 36397000
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
[No Abstract] [Full Text] [Related]
7. Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden.
Petersen MM; Kleif J; Jørgensen LN; Hendel JW; Seidelin JB; Madsen MR; Vilandt J; Brandsborg S; Rasmussen JS; Andersen LM; Khalid A; Ferm L; Gawel SH; Martens F; Andersen B; Rasmussen M; Davis GJ; Christensen IJ; Therkildsen C
Clin Colorectal Cancer; 2023 Jun; 22(2):199-210. PubMed ID: 36878807
[TBL] [Abstract][Full Text] [Related]
8. Participation and yield of a population-based colorectal cancer screening programme in China.
Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
[TBL] [Abstract][Full Text] [Related]
9. Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.
Zhang M; Zhang Y; Zhang W; Zhao L; Jing H; Wu X; Guo L; Zhang H; Zhang Y; Zhu S; Zhang S; Zhang X
Cancer Med; 2023 May; 12(10):11816-11827. PubMed ID: 36951442
[TBL] [Abstract][Full Text] [Related]
10. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
[TBL] [Abstract][Full Text] [Related]
11. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
12. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
[TBL] [Abstract][Full Text] [Related]
13. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.
Li JB; Ke KJ; Zhang WL; Wang LY; Wu YP; Weng F; Tian H; Qiu ZY; Li Y; Lin SY; Ye MX; Ou QJ; Gong CH; Lu ZH; Pan ZZ; Wan DS; Peng JH; Fang YJ
Cancer Med; 2022 Nov; 11(22):4321-4331. PubMed ID: 35441812
[TBL] [Abstract][Full Text] [Related]
15. Fecal MicroRNA-Based Algorithm Increases Effectiveness of Fecal Immunochemical Test-Based Screening for Colorectal Cancer.
Duran-Sanchon S; Moreno L; Gómez-Matas J; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Serradesanferm A; Pozo À; Grau J; Pellisé M; Gironella M; Castells A
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):323-330.e1. PubMed ID: 32113893
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
17. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
[TBL] [Abstract][Full Text] [Related]
18. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.
Jeon J; Du M; Schoen RE; Hoffmeister M; Newcomb PA; Berndt SI; Caan B; Campbell PT; Chan AT; Chang-Claude J; Giles GG; Gong J; Harrison TA; Huyghe JR; Jacobs EJ; Li L; Lin Y; Le Marchand L; Potter JD; Qu C; Bien SA; Zubair N; Macinnis RJ; Buchanan DD; Hopper JL; Cao Y; Nishihara R; Rennert G; Slattery ML; Thomas DC; Woods MO; Prentice RL; Gruber SB; Zheng Y; Brenner H; Hayes RB; White E; Peters U; Hsu L;
Gastroenterology; 2018 Jun; 154(8):2152-2164.e19. PubMed ID: 29458155
[TBL] [Abstract][Full Text] [Related]
19. The Implementation and First-Round Results of a Community-Based Colorectal Cancer Screening Program in Shanghai, China.
Gong Y; Peng P; Bao P; Zhong W; Shi Y; Gu K; Zheng Y; Wu C; Cai S; Xu Y; Sheng J; Wu F
Oncologist; 2018 Aug; 23(8):928-935. PubMed ID: 29540604
[TBL] [Abstract][Full Text] [Related]
20. One-sample quantitative and two-sample qualitative faecal immunochemical tests for colorectal cancer screening: a cross-sectional study in China.
Wang L; Chen H; Zhu Y; Lu M; Wang Y; Chen X; Ma W; Du L; Chen W
BMJ Open; 2022 May; 12(5):e059754. PubMed ID: 35589365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
